Shares of T2 Biosystems (TTOO) have fallen by roughly 75% since the company's IPO was priced at $11 in 2014. Over the past 3 years, the share price has lost roughly two-thirds of its value and so far 2019 has seen further decline.
Limited: it’s no easy task trying to evaluate identify trading opportunities in price trends and patterns seen in...
PKTX is where CSBR was 3 years ago.
PKTX's AAGP molecule is life changing.
Data is coming. With that comes higher stock price.
Those of you who have been following me the last few years, because of my call on Champions Oncology, CSBR, know that I have been predicting that ProtoKinetix PKTX is destined to be my next CSBR. The dynamics of each company...
Following my ideas redarding #cellectis. A promising french biotech company that already celebrates hugh success with "their" ucart19 against leukemia. Check out my thoughts and join the conversatioin.
- Double bottom which is normally an indicator for a reversal.
- higher high and higher low
- Oversold Stoch RSI (4hr)
Results of IFN Kinoide on Lupus research are very significant (95% efficacy observed). Volume increase strongly on the biotech and strong breakout of the 0.25 resistance has been observed. Pullback on the 0.25 level is resolved and the stock is now in perfect conditions for a bullish rally. First target is 0.5
The price is at the lowest area since its listing on OMXC. The price have been down with 90 %.
RSI combined with price shows (look at the red arrows at RSI) that while price is making Lower lows, the RSI is makin Lower highs, which shows that strength of sellers is weakned. This is typical sign of bottom is about to be made.
4H technical shows a bearish 20-50...
The biotech sector is really interesting when you dive down into the symmetry of the last few cycles. Early 2000s-2008 and 2016-2018 are mini rallies within the bigger wedge. If this pattern is to continues, you can look for entry around the end of 2020 when we bump up against the larger support line (around $3600), and expect to hit the resistance of the larger...
Target 10,000. I can't believe I said that... but there is just too much confluence to ignore this possibility. However, a breakdown from this wedge will likely eliminate this play. Either we hit it fast in 2019, or this long is off the table. Let me know your thoughts.
Psychology of a Market Cycle Cheat Sheet: goo.gl
IBB's chart is identical to the chart on the market psychology cheat sheet linked above.
IBB 5-wave cycle is over + Truncated 5th
Algorithms exit the market after extended 3rd waves, leaving the 5th with no volume nor liquidity, just as it's done for IBB .
Current Market Condition:...
My plan here is to layer into the market. The market is on fire but I believe that just opens up room for more profit when everything comes back together. Everyday the Biotech market falls, add more shares. Could see master gains here into 2019. Be patient and believe in the market.
100% fib extension coincides with resistance level from ER gap down at the end of February.
Stock has not only weathered the recent market sell off but also printing a bull flag.
Anticipating a continuation of advance coupled with increased volume.
This is the weekly chart on Loxo Oncology. This biotech focuses on cancer treatments by targeting genetic mutations that create protein chimers that lead to unregulated cellular proliferation. In English, and very simply, imagine a copy machine. When you press 'Copy' you should get one duplicate of the item you want copied. Cells have similar systems where a...